glp 1 agonist indications The expanding benefits of GLP-1 medicines: Cell Reports Medicine Frontiers | Clinical perspectives on
Description
6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease

Annahern J, Kruger DF, Gatcomb PM, Petit WA, Tamborlane WV (1989) The Diabetes Control and Complications Trial (DCCT): the trial coordinator perspective

Since brain GLP-1R signaling is to a large extent directly triggered by its peripheral secretion from the intestines via vagal stimulation of the NTS neurons, it seems plausible that proper balance in gut microbiota abundance and diversity can influence action of this peptide in the central nervous system

Amid the excitement of these new developments it is important to remember that attention to lifestyle factors remains the most fundamental means of tackling both T2D and obesity

LiQXGaoHGuoYXWangBYHuaRXGaoLet al

KEY OBSERVATIONS Chat starts with an AI assistant, but requesting a real person connected me immediately
